- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00472173
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth (APEXMTA)
November 9, 2011 updated by: Assistance Publique - Hôpitaux de Paris
Pulp necrosis is one of the main complication of dental trauma.
When it happens on an immature tooth, pulp necrosis implies a lack of root maturation and apical closure.
A therapy called apexification is required to induce the formation of a calcified apical barrier allowing a permanent and hermetic root filling.The aim of this study is to compare the efficacy of a new apexification method using Mineral Trioxide Aggregate (MTA®) with the reference treatment based on calcium hydroxide repeated stimulations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
36 patients aged 6 to 18 and presenting a non vital immature tooth will be included in the study (inclusion period: 12 months).
These patients will be randomly divided into two groups: one treated with MTA®, and the other one with calcium hydroxide.
For each patient, the total duration of the study will be 12 months.
Recalls will be performed at 15 and 21 days and then at 3, 6 and 12 months to assess by clinical and X-ray exams the main success criterion: presence of a calcified apical barrier or not.
Additional criterions such as presence of clinical symptoms or not, apical morphology and depth of this apical barrier will be observed.
This randomised prospective therapeutic study will allow to assess the ability of MTA® inducing apexification of a non vital immature tooth.
Furthermore, it will be possible to compare for both materials the kinetics of clinical symptoms disappearance and the morphology and depth of apices.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75018
- Hôpital Bretonneau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Indication of apexification treatment of an anterior immature tooth
- Patients aged 6 to 18
- Enlightened agreement of the patient and his/her legal representatives
- Prerequisite medical examination
Exclusion Criteria:
General disease
- diabetes
- immunosuppression of whatever origin (AIDS, drugs, …)
- severe asthma
- chronical disease requiring treatment
- eating disorders (anorexia, bulimia, malnutrition, …) Oral disease
- periodontal disease
- Administration of corticoids in a period of 3 months preceding the inclusion
- Patient with no social security cover
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Calcium hydroxide
|
Apexification treatment of the tooth with Calcium hydroxide
|
EXPERIMENTAL: MTA
|
Apexification treatment of the tooth with Mineral Trioxide Aggregate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Main success criterion: presence of a calcified apical barrier or not at 3, 6 and 12 months
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Additional criterions :- presence of clinical symptoms or not- apical morphology - depth of this apical barrier At 3, 6 and 12 months
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jean-Jacques Lasfargues, Dentist PhD, Hôpital Bretonneau - Paris
- Study Director: Raphaël SERREAU, MD, PhD, URC Paris Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (ACTUAL)
November 1, 2010
Study Completion (ACTUAL)
May 1, 2011
Study Registration Dates
First Submitted
May 10, 2007
First Submitted That Met QC Criteria
May 10, 2007
First Posted (ESTIMATE)
May 11, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
November 10, 2011
Last Update Submitted That Met QC Criteria
November 9, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P06236
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Pulp Necrosis
-
University of SulaimaniCompletedPulp Disease, Dental | Pulp MummificationIraq
-
Cairo UniversityCompletedDental Pulp Necrosis | Dental Pulp Disease | Dental Pulp; DegenerationEgypt
-
CAO Group, Inc.Sao Paulo State University, School of Dentistry at Aracatuba, Sao Paulo,...Completed
-
Cairo UniversityUnknown
-
Faculty of Dental Medicine for GirlsCompleted
-
Fifth Affiliated Hospital of Guangzhou Medical...Not yet recruiting
-
Cairo UniversityNot yet recruitingPulp Necroses
-
Southern Medical University, ChinaStomatological Hospital, Southern Medical University; Shenzhen Hospital, Southern...Recruiting
-
Cairo UniversityUnknown
Clinical Trials on Calcium hydroxide
-
British University In EgyptRecruitingEndodontic Disease | Pulp Disease, DentalEgypt
-
Minia UniversityUnknown
-
Cairo UniversityCompletedPain | Postoperative | Discomfort | Root Canal Retreatment | Calcium Hydroxide | Intracanal Medicament | Ache | Retreatment | Nonsurgical Retreatment | Endodontic Failure | Symptomatic Endodontic Failure | Nanosilver | Intracanal Dressing | AgNPs | Ca (OH)2 | Flare up | Post-operative | Post ObturationEgypt
-
Atatürk UniversityCompletedPeriapical; InfectionTurkey
-
Cairo UniversityCompleted
-
Universidad de los Andes, ChileCompletedCaries | Dental Pulp ExposureChile
-
NovartisCompletedHeartburnUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Cairo UniversityUnknown